
I attended a press conference at Institut Jantung Negara (IJN) today and witnessed a groundbreaking moment in Malaysian healthcare. IJN has officially become the first medical centre in Southeast Asia to successfully implant a dual-chamber leadless pacemaker—the Abbott AVEIR™ DR. This next-generation cardiac device marks a major step forward in the treatment of patients with slow or irregular heart rhythms, also known as bradycardia.

What Is the AVEIR™ DR Dual-Chamber Leadless Pacemaker?
Unlike traditional pacemakers, which are placed under the skin with long wires (leads) running to the heart, the AVEIR™ DR system is completely leadless. It involves two small devices implanted directly inside the upper (atrium) and lower (ventricle) chambers of the heart. This configuration allows for natural, synchronized pacing—closely mimicking the heart’s own rhythm.


The system is powered by Abbott’s i2i™ communication technology, which enables the two devices to communicate wirelessly through blood signals. No physical wires are needed, reducing the risks of infections, lead dislodgement, or vein blockage—all common complications of traditional pacemakers.

What Heart Patients Need to Know About This Innovation
This advancement is especially important for people living with bradycardia or other heart rhythm disorders. The dual-chamber pacing allows more precise treatment and improves patient comfort and mobility. The AVEIR™ DR pacemaker is also minimally invasive, has long-term retrievability, and allows for future device upgrades, making it a safer, smarter solution for long-term heart care.
According to IJN’s CEO, Prof. Dato’ Sri Dr. Mohamed Ezani Md Taib, this achievement reinforces IJN’s role as a regional leader in cardiovascular treatment. With heart disease remaining a top health concern in Malaysia and beyond, innovations like this are essential for better outcomes and longer lives.
IJN’s Role in Advancing Cardiac Technology
IJN has long been a pioneer in heart care. In 2018, it was among the first hospitals outside the United States to implant the world’s smallest pacemaker, the Micra AV. Now, with the AVEIR™ DR, IJN is once again setting new standards—not just in Malaysia, but across Southeast Asia.
As of now, 18 patients have received the new device, with the first successful implantation taking place on 27 May 2025. This achievement builds upon IJN’s decade of expertise in leadless pacemaker technology, during which close to 900 patients have been treated with wireless pacing devices.
This milestone also aligns with IJN’s commitment to early intervention, patient education, and cutting-edge cardiac solutions that deliver real-world impact.

Better Quality of Life for Heart Patients in Malaysia and Southeast Asia
For patients who need dual-chamber pacing but want to avoid the complications of leads and surgical pockets, this leadless pacemaker offers a life-changing alternative. The AVEIR™ DR system provides effective rhythm management while improving patient safety, reducing hospital stays, and enhancing quality of life.
If you or a loved one has been diagnosed with heart rhythm disorders, I suggest you to speak to a cardiologist about this new option. Thanks to IJN’s continued innovation, world-class heart care is now available right here in Malaysia.
IJN’s website: www.ijn.com.my






